Federal contract award
70US0923F3OTH2438
DRUG TESTING SERVICES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Homeland Security |
| Office | U. S. SECRET SERVICE |
| NAICS | 621999 — All Other Miscellaneous Ambulatory Health Care Services |
| PSC | Q999 — Other Medical Services |
| Parent award / vehicle | 140D0423D0020 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $268.6K |
| Current contract value | $268.6K |
| Potential contract value / ceiling | $321.5K |
| Start date | Apr 5, 2023 |
| Current end date | Apr 4, 2027 |
| Potential end date | Apr 4, 2028 |
| Latest award activity | Jun 3, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 3, 2026 | P00007 | $99.9K | THIS MODIFICATION IS TO FULLY FUND OPTION YEAR 3 (CLIN 0004) IN THE AMOUNT OF $99,939.35 FOR DRUG TESTING LABORATORY SERVICES |
| Apr 21, 2026 | P00006 | $0 | THIS MODIFICATION IS TO DE-OBLIGATE FUNDS IN THE AMOUNT OF $11,800.00 (CLIN 0003) AND RE-OBLIGATE FUNDS IN THE AMOUNT OF $11,800.00 (CLIN 0006) FOR OPTION YEAR 2 FOR DRUG TESTING SERVICES. |
| Apr 3, 2026 | P00005 | $0 | 1. EXERCISE OPTION YEAR 3 (CLIN 0004) FOR DRUG TESTING SERVICES SUBJECT TO THE AVAILABILITY OF FUNDS. THE PERIOD OF PERFORMANCE IS APRIL 5, 2026, TO APRIL 4, 2027. 2. INCORPORATE CLAUSE FAR 52.232-18, AVAILABILITY OF FUNDS (APR 1984) |
| Feb 3, 2026 | P00004 | $11.8K | THIS MODIFICATION IS TO ADD FUNDING TO OPTION YEAR 2 CLIN 0003 IN THE AMOUNT OF 11,800.00.00 FOR DRUG TESTING SERVICES. PSC Q999 |
| Sep 10, 2025 | P00003 | $6.6K | THIS MODIFICATION IS TO ADD FUNDING TO OPTION YEAR 2 CLIN 0003 IN THE AMOUNT OF $6625.00 FOR DRUG TESTING SERVICES. PSC Q999 |
| Apr 4, 2025 | P00002 | $51.0K | PER EO 14222 EXCEPTION 4(A): THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION YEAR 2 ON THE CONTRACT AND FUND IN THE AMOUNT OF $51,013.90. |
| Apr 1, 2024 | P00001 | $50.1K | EXERCISE OPTION YEAR 1 |
| Apr 5, 2023 | 0 | $49.2K | DRUG TESTING SERVICES |
Estimated positioning window
Apr 4, 2027 – Oct 4, 2027
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2028-04-04 (527 days from calculation)
- +25 points
- 3 historical awards in this buyer and category group
- +10 points
- 8 recorded award transactions
- +10 points
- Latest award action: 2026-06-03
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.